Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of selective neurogenic blockade on perioperative immune response in patients undergoing lung resection
2005-001456-20Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine, clonidine and remifentanil (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Immediate postoperative T-cell mediated immune reactivity. Started Nov 2005; status: completed.
02
Drugs
ropivacaineclonidineremifentanil
Beyond the preview
Go deeper on 2005-001456-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001456-20.